Search results
Results from the WOW.Com Content Network
1555 13088 Ensembl ENSG00000197408 ENSMUSG00000030483 UniProt P20813 P12791 RefSeq (mRNA) NM_000767 NM_009999 RefSeq (protein) NP_000758 n/a Location (UCSC) Chr 19: 40.99 – 41.02 Mb Chr 7: 25.6 – 25.63 Mb PubMed search Wikidata View/Edit Human View/Edit Mouse Cytochrome P450 2B6 is an enzyme that in humans is encoded by the CYP2B6 gene. CYP2B6 is a member of the cytochrome P450 group of ...
Cytochrome P450 2C19 (abbreviated CYP2C19) is an enzyme protein. It is a member of the CYP2C subfamily of the cytochrome P450 mixed-function oxidase system. This subfamily includes enzymes that catalyze metabolism of xenobiotics, including some proton pump inhibitors and antiepileptic drugs.
8529 72054 Ensembl ENSG00000186115 ENSMUSG00000003484 UniProt P78329 Q99N16 RefSeq (mRNA) NM_001082 NM_024444 RefSeq (protein) NP_001073 NP_077764 Location (UCSC) Chr 19: 15.88 – 15.9 Mb Chr 8: 72.74 – 72.76 Mb PubMed search Wikidata View/Edit Human View/Edit Mouse Cytochrome P450 4F2 is a protein that in humans is encoded by the CYP4F2 gene. This protein is an enzyme, a type of protein ...
CYP2C9 is a crucial cytochrome P450 enzyme, which plays a significant role in the metabolism, by oxidation, of both xenobiotic and endogenous compounds. [7] CYP2C9 makes up about 18% of the cytochrome P450 protein in liver microsomes. The protein is mainly expressed in the liver, duodenum, and small intestine. [7]
1548 13087 Ensembl ENSG00000255974 ENSMUSG00000005547 UniProt P11509 P20852 RefSeq (mRNA) NM_000762 NM_007812 RefSeq (protein) NP_000753 n/a Location (UCSC) Chr 19: 40.84 – 40.85 Mb Chr 7: 26.53 – 26.54 Mb PubMed search Wikidata View/Edit Human View/Edit Mouse Cytochrome P450 2A6 (abbreviated CYP2A6) is a member of the cytochrome P450 mixed-function oxidase system, which is involved in the ...
Effects on P450 isozyme activity are a major source of adverse drug interactions, since changes in P450 enzyme activity may affect the metabolism and clearance of various drugs. For example, if one drug inhibits the P450-mediated metabolism of another drug, the second drug may accumulate within the body to toxic levels.
CYP2E1 is a membrane protein expressed in high levels in the liver, where it composes nearly 50% of the total hepatic cytochrome P450 mRNA [8] and 7% of the hepatic cytochrome P450 protein. [9] The liver is therefore where most drugs undergo deactivation by CYP2E1, either directly or by facilitated excretion from the body.
Cytochrome P450 reductase (also known as NADPH:ferrihemoprotein oxidoreductase, NADPH:hemoprotein oxidoreductase, NADPH:P450 oxidoreductase, P450 reductase, POR, CPR, CYPOR) is a membrane-bound enzyme required for electron transfer from NADPH to cytochrome P450 [5] and other heme proteins including heme oxygenase in the endoplasmic reticulum [6] of the eukaryotic cell.